메뉴 건너뛰기




Volumn 167, Issue 1, 2012, Pages 49-57

Impact of short-term high-fat feeding and insulin-stimulated FGF21 levels in subjects with low birth weight and controls

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR 21; INSULIN;

EID: 84862747013     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-12-0039     Document Type: Article
Times cited : (44)

References (39)
  • 1
    • 33845881411 scopus 로고    scopus 로고
    • Mechanisms linking obesity to insulin resistance and type 2 diabetes
    • doi:10.1038/nature05482
    • Kahn SE, Hull RL & Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 2006 444 840-846. (doi:10.1038/nature05482)
    • (2006) Nature , vol.444 , pp. 840-846
    • Kahn, S.E.1    Hull, R.L.2    Utzschneider, K.M.3
  • 3
    • 70350322694 scopus 로고    scopus 로고
    • Fibroblast growth factor 21-deficient mice demonstrate impaired adaptation to ketosis
    • doi:10.1210/en.2009-0532
    • Badman MK, Koester A, Flier JS, Kharitonenkov A & Maratos-Flier E. Fibroblast growth factor 21-deficient mice demonstrate impaired adaptation to ketosis. Endocrinology 2009 150 4931-4940. (doi:10.1210/en.2009-0532)
    • (2009) Endocrinology , vol.150 , pp. 4931-4940
    • Badman, M.K.1    Koester, A.2    Flier, J.S.3    Kharitonenkov, A.4    Maratos-Flier, E.5
  • 4
    • 33750587755 scopus 로고    scopus 로고
    • Fibroblast growth factor-21 improves pancreatic-cells function and survival by activation of extracellular signal-regulated kinase 1/2 and Akt signaling pathway
    • doi:10.2337/db05-1435
    • Wente W, Efanov AM, Brenner M, Kharitonenkov A, Köster A, Sandusky GE, Sewing S, Treinies I, Zitzer H & Gromada J. Fibroblast growth factor-21 improves pancreatic-cells function and survival by activation of extracellular signal-regulated kinase 1/2 and Akt signaling pathway. Diabetes 2006 55 2470-2478. (doi:10.2337/db05-1435)
    • (2006) Diabetes , vol.55 , pp. 2470-2478
    • Wente, W.1    Efanov, A.M.2    Brenner, M.3    Kharitonenkov, A.4    Köster, A.5    Sandusky, G.E.6    Sewing, S.7    Treinies, I.8    Zitzer, H.9    Gromada, J.10
  • 5
    • 34249711964 scopus 로고    scopus 로고
    • Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states
    • doi:10.1016/j.cmet.2007.05.002
    • Badman MK, Pissios P, Kennedy AR, Koukos G, Flier JS & Maratos-Flier E. Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states. Cell Metabolism 2007 5 426-437. (doi:10.1016/j.cmet.2007.05.002)
    • (2007) Cell Metabolism , vol.5 , pp. 426-437
    • Badman, M.K.1    Pissios, P.2    Kennedy, A.R.3    Koukos, G.4    Flier, J.S.5    Maratos-Flier, E.6
  • 14
    • 47949111205 scopus 로고    scopus 로고
    • Adipose fibroblast growth factor 21 is up-regulated by peroxisome proliferator-activated receptor gamma and altered metabolic states
    • doi:10.1124/mol.108.044826
    • Muise ES, Azzolina B, Kuo DW, El-Sherbeini M, Tan Y, Yuan X,Mu J, Thompson JR, Berger JP & Wong KK. Adipose fibroblast growth factor 21 is up-regulated by peroxisome proliferator-activated receptor gamma and altered metabolic states. Molecular Pharmacology 2008 74 403-412. (doi:10.1124/mol.108. 044826)
    • (2008) Molecular Pharmacology , vol.74 , pp. 403-412
    • Muise, E.S.1    Azzolina, B.2    Kuo, D.W.3    El-Sherbeini, M.4    Tan, Y.5    Yuan, X.6    Mu, J.7    Thompson, J.R.8    Berger, J.P.9    Wong, K.K.10
  • 18
    • 48349146527 scopus 로고    scopus 로고
    • Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans
    • doi:10.2337/db07-1476
    • Zhang X, Yeung DC, Karpisek M, Stejskal D, Zhou ZG, Liu F, Wong RL, Chow WS, Tso AW, Lam KS & Xu A. Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans. Diabetes 2008 57 1246-1253. (doi:10.2337/db07-1476)
    • (2008) Diabetes , vol.57 , pp. 1246-1253
    • Zhang, X.1    Yeung, D.C.2    Karpisek, M.3    Stejskal, D.4    Zhou, Z.G.5    Liu, F.6    Wong, R.L.7    Chow, W.S.8    Tso, A.W.9    Lam, K.S.10    Xu, A.11
  • 21
    • 77957359658 scopus 로고    scopus 로고
    • Fibroblast growth factor 21 levels are increased in nonalcoholic fatty liver disease patients and are correlated with hepatic triglyceride
    • doi:10.1016/j.jhep.2010.05.018
    • Li H, Fang Q, Gao F, Fan J, Zhou J,Wang X, Zhang H, Pan X, Bao Y, Xiang K, Xu A & Jia W. Fibroblast growth factor 21 levels are increased in nonalcoholic fatty liver disease patients and are correlated with hepatic triglyceride. Journal of Hepatology 2010 53 934-940. (doi:10.1016/j.jhep.2010. 05.018)
    • (2010) Journal of Hepatology , vol.53 , pp. 934-940
    • Li, H.1    Fang, Q.2    Gao, F.3    Fan, J.4    Zhou, J.5    Wang, X.6    Zhang, H.7    Pan, X.8    Bao, Y.9    Xiang, K.10    Xu, A.11    Jia, W.12
  • 24
    • 16844380699 scopus 로고    scopus 로고
    • Low birth weight is associated with specific changes in muscle insulin signaling protein expression
    • doi:10.1007/s00125-005-1669-7
    • Ozanne SE, Jensen CB, Tingey KJ, Storgaard H, Madsbad S &Vaag AA. Low birth weight is associated with specific changes in muscle insulin signaling protein expression. Diabetologia 2005 48 547-552. (doi:10.1007/s00125-005-1669- 7)
    • (2005) Diabetologia , vol.48 , pp. 547-552
    • Ozanne, S.E.1    Jensen, C.B.2    Tingey, K.J.3    Storgaard, H.4    Madsbad, S.5    Vaag, A.A.6
  • 25
    • 33750902947 scopus 로고    scopus 로고
    • Decreased protein levels of key insulin signalling molecules in adipose tissue from young men with a low birthweight - Potential link to increased risk of diabetes?
    • doi:10.1007/s00125-006-0466-2
    • Ozanne SE, Jensen CB, Tingey KJ, Martin-Gronert MS, Grunnet L, Brons C, Storgaard H & Vaag AA. Decreased protein levels of key insulin signalling molecules in adipose tissue from young men with a low birthweight - potential link to increased risk of diabetes? Diabetologia 2006 49 2993-2999. (doi:10.1007/s00125-006-0466-2)
    • (2006) Diabetologia , vol.49 , pp. 2993-2999
    • Ozanne, S.E.1    Jensen, C.B.2    Tingey, K.J.3    Martin-Gronert, M.S.4    Grunnet, L.5    Brons, C.6    Storgaard, H.7    Vaag, A.A.8
  • 29
    • 0025043679 scopus 로고
    • Prediction of 24-h energy expenditure and its components from physical characteristics and body composition in normal-weight humans
    • Astrup A, Thorbek G, Lind J & Isaksson B. Prediction of 24-h energy expenditure and its components from physical characteristics and body composition in normal-weight humans. American Journal of Clinical Nutrition 1990 52 777-783.
    • (1990) American Journal of Clinical Nutrition , vol.52 , pp. 777-783
    • Astrup, A.1    Thorbek, G.2    Lind, J.3    Isaksson, B.4
  • 30
    • 0028819524 scopus 로고
    • Glucose processing during the intravenous glucose tolerance test
    • doi:10.1007/BF00400638
    • Vaag A, Alford F, Henriksen FL, Christopher M & Beck-Nielsen H. Glucose processing during the intravenous glucose tolerance test. Diabetologia 1995 38 326-336. (doi:10.1007/BF00400638)
    • (1995) Diabetologia , vol.38 , pp. 326-336
    • Vaag, A.1    Alford, F.2    Henriksen, F.L.3    Christopher, M.4    Beck-Nielsen, H.5
  • 31
    • 0028802645 scopus 로고
    • Loss of hepatic autoregulation after carbohydrate overfeeding in normal man
    • doi:10.1172/JCI118243
    • Clore JN, Helm ST & Blackard WG. Loss of hepatic autoregulation after carbohydrate overfeeding in normal man. Journal of Clinical Investigation 1995 96 1967-1972. (doi:10.1172/JCI118243)
    • (1995) Journal of Clinical Investigation , vol.96 , pp. 1967-1972
    • Clore, J.N.1    Helm, S.T.2    Blackard, W.G.3
  • 32
    • 33747075400 scopus 로고    scopus 로고
    • The effects of shortterm overfeeding on insulin action in lean and reducedobese individuals
    • doi:10.1016/j.metabol.2006.05.003
    • Cornier MA, Bergman BC & Bessesen DH. The effects of shortterm overfeeding on insulin action in lean and reducedobese individuals. Metabolism 2006 55 1207-1214. (doi:10.1016/j.metabol.2006.05.003)
    • (2006) Metabolism , vol.55 , pp. 1207-1214
    • Cornier, M.A.1    Bergman, B.C.2    Bessesen, D.H.3
  • 33
    • 43549110007 scopus 로고    scopus 로고
    • FGF21 attenuates lipolysis in human adipocytes - A possible link to improved insulin sensitivity
    • doi:10.1016/j.febslet.2008.04.038
    • Arner P, Pettersson A, Mitchell PJ, Dunbar JD, Kharitonenkov A &Rydén M. FGF21 attenuates lipolysis in human adipocytes - a possible link to improved insulin sensitivity. FEBS Letters 2008 582 1725-1730. (doi:10.1016/j.febslet.2008.04.038)
    • (2008) FEBS Letters , vol.582 , pp. 1725-1730
    • Arner, P.1    Pettersson, A.2    Mitchell, P.J.3    Dunbar, J.D.4    Kharitonenkov, A.5    Rydén, M.6
  • 34
    • 70349472910 scopus 로고    scopus 로고
    • Inhibition of lipolysis may contribute to the acute regulation of plasma FFA and glucose by FGF21 in ob/ob mice
    • doi:10.1016/j.febslet.2009.09.012
    • Li X, Ge H,Weiszmann J, Hecht R, Li YS, Véniant MM, Xu J,Wu X, Lindberg R & Li Y. Inhibition of lipolysis may contribute to the acute regulation of plasma FFA and glucose by FGF21 in ob/ob mice. FEBS Letters 2009 583 3230-3234. (doi:10.1016/j.febslet.2009.09.012)
    • (2009) FEBS Letters , vol.583 , pp. 3230-3234
    • Li, X.1    Ge, H.2    Weiszmann, J.3    Hecht, R.4    Li, Y.S.5    Véniant, M.M.6    Xu, J.7    Wu, X.8    Lindberg, R.9    Li, Y.10
  • 35
    • 79956113302 scopus 로고    scopus 로고
    • Circadian rhythm of circulating fibroblast growth factor 21 is related to diurnal changes in fatty acids in humans
    • doi:10.1373/clinchem.2010.155184
    • Yu H, Xia F, Lam KS, Wang Y, Bao Y, Zhang J, Gu Y, Zhou P, Lu J, Jia W & Xu A. Circadian rhythm of circulating fibroblast growth factor 21 is related to diurnal changes in fatty acids in humans. Clinical Chemistry 2011 57 691-700. (doi:10.1373/clinchem.2010.155184)
    • (2011) Clinical Chemistry , vol.57 , pp. 691-700
    • Yu, H.1    Xia, F.2    Lam, K.S.3    Wang, Y.4    Bao, Y.5    Zhang, J.6    Gu, Y.7    Zhou, P.8    Lu, J.9    Jia, W.10    Xu, A.11
  • 36
    • 80052519903 scopus 로고    scopus 로고
    • Plasma FGF21 displays a circadian rhythm during a 72-h fast in healthy female volunteers
    • doi:10.1111/j.1365-2265.2011.04084.x
    • Andersen B, Beck-Nielsen H & Højlund K. Plasma FGF21 displays a circadian rhythm during a 72-h fast in healthy female volunteers. Clinical Endocrinology 2011 75 514-519. (doi:10.1111/j.1365-2265.2011.04084.x)
    • (2011) Clinical Endocrinology , vol.75 , pp. 514-519
    • Andersen, B.1    Beck-Nielsen, H.2    Højlund, K.3
  • 37
    • 79954525448 scopus 로고    scopus 로고
    • Circulating FGF21 levels are progressively increased from the early to end stages of chronic kidney diseases and are associated with renal function in Chinese
    • doi:10.1371/journal.pone.0018398
    • Lin Z, Zhou Z, Liu Y, Gong Q, Yan X, Xiao J,Wang X, Lin S, FengW & Li X. Circulating FGF21 levels are progressively increased from the early to end stages of chronic kidney diseases and are associated with renal function in Chinese. PLoS ONE 2011 6 e18398. (doi:10.1371/journal.pone.0018398)
    • (2011) PLoS ONE , vol.6
    • Lin, Z.1    Zhou, Z.2    Liu, Y.3    Gong, Q.4    Yan, X.5    Xiao, J.6    Wang, X.7    Lin, S.8    Feng, W.9    Li, X.10
  • 39
    • 77955434383 scopus 로고    scopus 로고
    • Fibroblast growth factor 21 regulates energy metabolism by activating the AMPK-SIRT1-PGC-1a pathway
    • doi:10.1073/pnas.1006962107
    • Chau MDL, Gao J, Yang Q, Wu Z & Gromada J. Fibroblast growth factor 21 regulates energy metabolism by activating the AMPK-SIRT1-PGC-1a pathway. PNAS 2010 107 12553-12558. (doi:10.1073/pnas.1006962107)
    • (2010) PNAS , vol.107 , pp. 12553-12558
    • Chau, M.D.L.1    Gao, J.2    Yang, Q.3    Wu, Z.4    Gromada, J.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.